Anti-atherosclerotic property of calcium channel blocker azelnidipine is based on its effects of anti-inflammation and antioxidation in patients with essential hypertension

被引：0
|
作者：
Yamakado, Minoru
Ishizaka, Yuko
Yano, Masao
Taira, Motohisa
机构：
来源：
JOURNAL OF HYPERTENSION | 2006年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：324 / 324
页数：1
相关论文
共 23 条
  • [1] Effect of calcium channel blocker, azelnidipine on glycation in patients with essential hypertension
    Yamakado, M
    Ishizaka, Y
    Shimomura, H
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 76A - 77A
  • [2] Anti-Inflammatory Properties of Azelnidipine, a Dihydropyridine-Based Calcium Channel Blocker
    Komoda, Hiroshi
    Inoue, Teruo
    Node, Koichi
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2010, 32 (02) : 121 - 128
  • [3] Azelnidipine has anti-atherosclerotic effects independent of its blood pressure-lowering actions in monkeys and mice
    Nakano, Kaku
    Egashira, Kensuke
    Ohtani, Kisho
    Gang, Zhao
    Iwata, Eiko
    Miyagawa, Miho
    Sunagawa, Kenji
    ATHEROSCLEROSIS, 2008, 196 (01) : 172 - 179
  • [4] Possible mechanism for the anti-atherosclerotic action of the calcium channel blocker AE0047 in cholesterol-fed rabbits
    Hayashi, K
    Imada, T
    Yamauchi, T
    Kido, H
    Shinyama, H
    Matzno, S
    Nakamura, N
    Kagitani, Y
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 (01) : 17 - 25
  • [5] Bazedoxifene exhibits anti-inflammation and anti-atherosclerotic effects via inhibition of IL-6/IL-6R/STAT3 signaling
    Luo, Pengcheng
    Wang, Yina
    Zhao, Chongqiang
    Guo, Junyi
    Shi, Wei
    Ma, Haiyan
    Liu, Tianshu
    Yan, Dan
    Huo, Shengqi
    Wang, Moran
    Li, Chenglong
    Lin, Jiayuh
    Li, Sheng
    Lv, Jiagao
    Zhang, Cuntai
    Lin, Li
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 893
  • [6] Acacetin, a Natural Flavone with Potential in Improving Liver Disease Based on Its Anti-Inflammation, Anti-Cancer, Anti-Infection and Other Effects
    Chen, Kuihao
    Gao, Zhe
    MOLECULES, 2024, 29 (20):
  • [7] MICROALBUMINURIA IN PATIENTS WITH ESSENTIAL-HYPERTENSION - EFFECTS OF AN ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR AND OF A CALCIUM-CHANNEL BLOCKER
    BIANCHI, S
    BIGAZZI, R
    BALDARI, G
    CAMPESE, VM
    AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (04) : 291 - 296
  • [8] EFFECTS OF A NEW CALCIUM-CHANNEL BLOCKER, NILVADIPINE, ON THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    TAKISHITA, S
    MURATANI, H
    TSUCHIHASHI, T
    TOMITA, Y
    UENO, M
    FUJISHIMA, M
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1990, 48 (03): : 417 - 426
  • [9] Effects of Anti-Hypertensive Monotherapy with Either Calcium Channel Blocker or Angiotensin Receptor Blocker on Arterial Stiffness, Central Hemodynamics, and Ventriculo-Arterial Coupling in Uncomplicated Hypertension Patients
    Lin, Heng-Hsu
    Wang, Chia-Sung
    Lin, Jiunn-Lee
    Hwang, Juey-Jen
    Lin, Lian-Yu
    ACTA CARDIOLOGICA SINICA, 2013, 29 (01) : 19 - 27
  • [10] ANTI-ANGINAL EFFECTS OF BEPRIDIL - A NEW CALCIUM-CHANNEL BLOCKER - IN PATIENTS WITH STABLE ANGINA-PECTORIS
    NARAHARA, KA
    SHAPIRO, W
    PARK, J
    WELIKY, I
    CLINICAL RESEARCH, 1983, 31 (01): : A15 - A15
123